Effect of exopolysaccharide V2-7, isolated from Halomonas eurihalina, on the proliferation in vitro of human peripheral blood lymphocytes

Immunopharmacol Immunotoxicol. 2000 Feb;22(1):131-41. doi: 10.3109/08923970009016411.

Abstract

The immunomodulatory activity of the exopolysaccharide V2-7, a sulfated polymer excreted by the moderately halophilic bacteria Halomonas eurihalina, was studied in vitro. [3H]thymidine incorporation and flow-cytometry measurements showed that this exopolysaccharide enhanced the unspecific proliferation of human lymphocytes in response to the presence of anti-CD3 monoclonal antibody. It was effective at concentrations of less than 1 microg/ml, maximum activity being achieved at 0.2 microg/ml.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Cell Division / drug effects
  • Cells, Cultured
  • Flow Cytometry
  • Halomonas / metabolism*
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Lymphocytes / drug effects*
  • Monocytes / drug effects
  • Monocytes / metabolism
  • Muromonab-CD3 / pharmacology
  • Polysaccharides, Bacterial / isolation & purification
  • Polysaccharides, Bacterial / pharmacology*
  • Stimulation, Chemical
  • Thymidine / metabolism

Substances

  • Adjuvants, Immunologic
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Polysaccharides, Bacterial
  • exopolysaccharide V2-7, Halomonas
  • Thymidine